Ubs Group Ag Exact Sciences Corp Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Exact Sciences Corp stock. As of the latest transaction made, Ubs Group Ag holds 26,100 shares of EXAS stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,100

Previous 215,824 87.91%

Holding current value

$1.13 Million

Previous $16 Million 88.71%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$56.27 - $73.77 $2.59 Million - $3.4 Million	46,107 Added 21.36%	261,931 $18.1 Million
Q4 2023 Feb 09, 2024	SELL	$59.06 - $75.72 $453,876 - $581,908	-7,685 Reduced 3.44%	215,824 $16 Million
Q3 2023 Nov 09, 2023	BUY	$65.94 - $99.04 $1.75 Million - $2.62 Million	26,485 Added 13.44%	223,509 $15.2 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $3.45 Million - $5.23 Million	55,027 Added 38.75%	197,024 $18.5 Million
Q1 2023 May 12, 2023	SELL	$47.19 - $70.77 $7.54 Million - $11.3 Million	-159,691 Reduced 52.93%	141,997 $9.63 Million

Q4 2022 Feb 08, 2023	BUY	$30.35 - $53.15 $4.36 Million - $7.63 Million	143,542 Added 90.77%	301,688 $14.9 Million
Q3 2022 Nov 10, 2022	SELL	$31.97 - $49.37 $495,982 - $765,926	-15,514 Reduced 8.93%	158,146 $5.14 Million
Q2 2022 Aug 10, 2022	SELL	$35.61 - $76.23 $2.8 Million - $5.99 Million	-78,590 Reduced 31.16%	173,660 $6.84 Million
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $4.91 Million - $7.04 Million	-85,247 Reduced 25.26%	252,250 $17.6 Million
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $2.64 Million - $3.67 Million	36,430 Added 12.1%	337,497 $26.3 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $8.21 Million - $11.3 Million	90,949 Added 43.28%	301,067 $28.7 Million
Q2 2021 Aug 13, 2021	SELL	$93.66 - $139.27 $5.59 Million - $8.32 Million	-59,715 Reduced 22.13%	210,118 $26.1 Million
Q1 2021 May 12, 2021	BUY	$116.57 - $155.01 $2.3 Million - $3.06 Million	19,719 Added 7.88%	269,833 $35.6 Million
Q4 2020 Feb 11, 2021	SELL	$99.61 - $142.12 $1.89 Million - $2.7 Million	-19,009 Reduced 7.06%	250,114 $33.1 Million
Q3 2020 Nov 12, 2020	SELL	$72.92 - $102.01 $1.52 Million - $2.13 Million	-20,854 Reduced 7.19%	269,123 $27.4 Million
Q2 2020 Jul 31, 2020	SELL	$55.75 - $92.75 $5.83 Million - $9.7 Million	-104,577 Reduced 26.51%	289,977 $25.2 Million
Q1 2020 May 01, 2020	BUY	$37.9 - $104.44 $3.98 Million - $11 Million	105,077 Added 36.3%	394,554 $22.9 Million
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $3.24 Million - $4.16 Million	-41,753 Reduced 12.61%	289,477 $26.8 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $518,362 - $702,602	5,736 Added 1.76%	331,230 $29.9 Million
Q2 2019 Aug 14, 2019	BUY	$89.51 - $118.04 $6.97 Million - $9.2 Million	77,920 Added 31.47%	325,494 $38.4 Million
Q1 2019 May 14, 2019	SELL	$61.98 - $96.5 $4.93 Million - $7.68 Million	-79,589 Reduced 24.33%	247,574 $21.4 Million
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $10.8 Million - $15.9 Million	191,977 Added 142.01%	327,163 $20.6 Million
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $1.48 Million - $2.47 Million	30,606 Added 29.27%	135,186 $10.7 Million
Q2 2018 Aug 14, 2018	SELL	$37.84 - $69.96 $3.46 Million - $6.4 Million	-91,467 Reduced 46.66%	104,580 $6.25 Million
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $2.55 Million - $3.69 Million	64,137 Added 48.62%	196,047 $7.91 Million
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $2.11 Million - $2.74 Million	-45,354 Reduced 25.59%	131,910 $6.93 Million
Q3 2017 Nov 14, 2017	SELL	$37.05 - $47.12 $47.6 Million - $60.6 Million	-1,285,801 Reduced 87.88%	177,264 $8.35 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,354,760 Added 1250.87%	1,463,065 $51.7 Million
Q1 2017 Nov 14, 2017	BUY	N/A	108,305	108,305 $2.56 Million

Others Institutions Holding EXAS

# of Institutions

699

Shares Held

160M

Call Options Held

5.84M

Put Options Held

2.58M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.64B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account